Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report

RATIONALE: There are roughly 5 to 10 million persons infected with human T-lymphotropic virus type 1 (HTLV-1) worldwide, and the safety of treating this population with biologics remains poorly understood. PATIENT CONCERNS AND DIAGNOSIS: An HTLV-1-infected 66-year-old female with HTLV-1 uveitis (HU)...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Yukiko, Kamoi, Koju, Ohno-Matsui, Kyoko, Miyata, Kazunori, Yamano, Chinami, Coler-Reilly, Ariella, Yamano, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312999/
https://www.ncbi.nlm.nih.gov/pubmed/28178142
http://dx.doi.org/10.1097/MD.0000000000006021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312999/
https://www.ncbi.nlm.nih.gov/pubmed/28178142
http://dx.doi.org/10.1097/MD.0000000000006021

Ejemplares similares